[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9703287D0 - Peptides - Google Patents

Peptides

Info

Publication number
SE9703287D0
SE9703287D0 SE9703287A SE9703287A SE9703287D0 SE 9703287 D0 SE9703287 D0 SE 9703287D0 SE 9703287 A SE9703287 A SE 9703287A SE 9703287 A SE9703287 A SE 9703287A SE 9703287 D0 SE9703287 D0 SE 9703287D0
Authority
SE
Sweden
Prior art keywords
peptide
nucleic acid
peptides
mog
screening
Prior art date
Application number
SE9703287A
Other languages
English (en)
Inventor
Magnus Andersson
Christopher Linington
Tomas Olsson
Erik Wallstroem
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9703287A priority Critical patent/SE9703287D0/sv
Publication of SE9703287D0 publication Critical patent/SE9703287D0/sv
Priority to EP98944386A priority patent/EP1012183A1/en
Priority to CA002301684A priority patent/CA2301684A1/en
Priority to AU91938/98A priority patent/AU9193898A/en
Priority to PCT/SE1998/001618 priority patent/WO1999012966A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
SE9703287A 1997-09-11 1997-09-11 Peptides SE9703287D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9703287A SE9703287D0 (sv) 1997-09-11 1997-09-11 Peptides
EP98944386A EP1012183A1 (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
CA002301684A CA2301684A1 (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
AU91938/98A AU9193898A (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
PCT/SE1998/001618 WO1999012966A1 (en) 1997-09-11 1998-09-11 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703287A SE9703287D0 (sv) 1997-09-11 1997-09-11 Peptides

Publications (1)

Publication Number Publication Date
SE9703287D0 true SE9703287D0 (sv) 1997-09-11

Family

ID=20408221

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703287A SE9703287D0 (sv) 1997-09-11 1997-09-11 Peptides

Country Status (5)

Country Link
EP (1) EP1012183A1 (sv)
AU (1) AU9193898A (sv)
CA (1) CA2301684A1 (sv)
SE (1) SE9703287D0 (sv)
WO (1) WO1999012966A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020072493A1 (en) 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
EP1080110A2 (en) * 1998-05-19 2001-03-07 Yeda Research And Development Co. Ltd. Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2170901A1 (en) * 1993-09-03 1995-03-09 Brigitte Devaux Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
WO1995007096A1 (en) * 1993-09-06 1995-03-16 La Trobe University Treatment of autoimmune disease
SI9520118A (sl) * 1994-10-25 1998-08-31 Immulogic Pharmaceutical Corporation Sestavki in zdravljenje multiple skleroze
CA2250361A1 (en) * 1996-03-28 1997-10-02 Barbara Wallner Myelin oligodendrocyte glycoprotein peptides and uses thereof

Also Published As

Publication number Publication date
CA2301684A1 (en) 1999-03-18
WO1999012966A1 (en) 1999-03-18
EP1012183A1 (en) 2000-06-28
AU9193898A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
ATE386538T1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
EP2258383A3 (en) Antigenic peptides derived from telomerase
RU95115239A (ru) Аналог эритропоэтина
BR0213786A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
CY1111120T1 (el) Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
HUP0204199A2 (hu) Transzport vektorok
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
DE60213648D1 (de) Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
EP1071443A4 (en) ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE
ATE443076T1 (de) Von protease typ ii spaltbares peptid
NZ508505A (en) Treatment of wounds using an Egr-1 transcription factor polypeptide
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
SE9703287D0 (sv) Peptides
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
EP1702985A3 (en) Preferred segments of neural thread protein and methods of using the same
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DE69738600D1 (de) Neuroaktive peptide
ATE202114T1 (de) Verwendung von peptiden welche eine immunantwort bewirken zur herstellung von medikamenten zur induzierung der immunsuppression.
DE69726602D1 (en) Hepatitis b inhibitoren
NO973876L (no) Human-DNase I-varianter